Butterfly Network Posts Strong Q4 Beat, Sees Shares Surge on Revenue Growth and Improved Margins
Shares of Butterfly Network Inc (NYSE:BFLY) experienced a significant pre-market surge, climbing over 28%, following the release of its fourth-quarter 2025 financial results. The digital health company, known for its handheld, semiconductor-based ultrasound devices, reported revenue and earnings that comfortably exceeded analyst expectations, driven by a new strategic partnership and improved operational efficiency.
Earnings and Revenue: A Clear Beat
The company’s financial performance for the quarter ended December 31, 2025, showcased substantial growth and a notable narrowing of losses.
- Revenue: Butterfly reported Q4 revenue of $31.5 million, a 41% increase year-over-year. This figure significantly surpassed the analyst consensus estimate of approximately $26.4 million.
- Earnings Per Share (EPS): The company reported an adjusted EPS loss of $0.02, a marked improvement from the loss of $0.05 in the prior-year period. This result also beat the analyst estimate, which anticipated a larger loss of $0.06 per share.
The strong top-line performance was primarily fueled by U.S. revenue, which grew 55% year-over-year to $26.8 million. Management highlighted that this growth was driven by revenue from a new co-development partnership with Midjourney, which contributed $6.8 million in the quarter, as well as increased sales of its ultrasound probes.
Strategic Highlights and Business Transition
Beyond the headline numbers, the earnings press release emphasized Butterfly’s ongoing strategic pivot. CEO Joseph DeVivo stated the company is transitioning "from a medical device company into a transformative semiconductor-based company." Key operational highlights from the quarter include:
- The formal launch of the Butterfly Embedded™ brand, centralizing semiconductor co-development activities and positioning its proprietary Ultrasound-on-Chip™ technology as a long-term growth driver.
- The contribution from the Midjourney partnership, part of a larger agreement that could see up to $74 million in payments to Butterfly over five years.
- The launch of next-generation Compass™ AI enterprise software and the achievement of key U.S. government cloud security authorizations (GovRAMP, TX-RAMP), opening up federal and Department of Defense markets.
- Progress on the HomeCare commercialization initiative, with the first commercial agreement anticipated by mid-2026.
- Advancement of its R&D roadmap, moving its fifth-generation chip into production.
Financial Health and Forward Guidance
The company also achieved a significant milestone by generating its first-ever quarter of positive operating cash flow. It ended the quarter with a robust cash position of $150.5 million.
Butterfly provided guidance for the full fiscal year 2026, projecting:
- Revenue between $117 million and $121 million, representing growth of approximately 20% to 24%.
- An Adjusted EBITDA loss in the range of $21 million to $25 million.
This revenue outlook appears conservative when compared to the current analyst sales estimate for FY2026 of $108.6 million, suggesting management's forecast may be setting a baseline that exceeds market expectations.
Market Reaction and Valuation Context
The sharp pre-market rally is a direct reaction to the earnings beat and the improved profitability metrics. Investors are likely interpreting the results as validation of the company’s diversified strategy, which now blends device sales, software, and high-margin semiconductor licensing revenue. The latter was a key factor in boosting the company's gross margin to 67.3% in Q4, up from 61.4% a year ago.
While the stock has faced pressure over the past month, the Q4 report provides tangible evidence of accelerating growth and improved financial discipline. The focus will now shift to the company's ability to execute on its 2026 guidance, convert its Embedded and HomeCare initiatives into sustained revenue streams, and continue on its path toward profitability.
For a detailed breakdown of Butterfly Network’s historical earnings, future estimates, and analyst projections, you can review the data here.
Disclaimer: This article is for informational purposes only and does not constitute financial advice, an endorsement, or a recommendation to buy, sell, or hold any security. Investors should conduct their own research and consult with a qualified financial advisor before making any investment decisions.